arrow
G

György Trencsényi

university of debrecen
H指数:19
被引数:1,608

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhanced Tumor-to-Background Contrast with [52Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer

增强型肿瘤-背景对比度:[52Mn]Mn-BPPA-Bevacizumab VEGF靶向免疫PET在宫颈癌中的应用

2026-03-300
OAAI
Liquid chromatographic determination of enantiomeric purity of [11C]methyl-L-methionine and O-(2-[18F]fluoroethyl)-L-tyrosine by pre-column derivatization with o-phthaldialdehyde and N-isobutyryl-L-cysteine

通过邻苯二甲醛和N-异丁酰-L-半胱氨酸的柱前衍生液相色谱法测定 [11C] 甲基-L-蛋氨酸和O-(2-[18F] 氟乙基)-L-酪氨酸的对映体纯度

2026-01-070
OAAI
Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model

213bi-dota标记的 α-黑素细胞刺激素肽类似物在melanocortin-1受体阳性临床前黑色素瘤模型中的疗效评价

2023-09-012
OAAI
In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model
2023-05-015
OAAI
Therapeutic Performance Evaluation of 213Bi-Labelled Aminopeptidase N (APN/CD13)-Affine NGR-Motif ([213Bi]Bi-DOTAGA-cKNGRE) in Experimental Tumour Model: A Treasured Tailor for Oncology

213bi-标记的氨肽酶N (APN/CD13)-亲和NGR基序 ([213Bi] bi-dotaga-ckngre) 在实验性肿瘤模型中的治疗性能评估: 肿瘤学的珍贵裁缝

2023-02-012
OAAI